Back to search

Poland· PL-100434801

Dermatol APTEO MED

A other cicatrizants product containing bismuthi subgallas, registered in Poland by Synoptis Pharma Sp. z o.o.. The same ATC class is registered in 5 of our 19 countries.

ATC D03AX

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedDermatol APTEO MEDATCD03AXREGISTER NO.PL-100434801PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Bismuthi subgallas is registered in 5 of 19 countries.

Countries holding a registration under ATC D03AX (other cicatrizants), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 5 of them publish a price we can compare per daily dose

Bismuthi subgallas · ATC D03AX

5 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Finlandprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Bismuthi subgallas
Manufacturer
Synoptis Pharma Sp. z o.o.
Country
Poland (PL)
ATC code
D03AX
ATC class
Other cicatrizants
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    05909991482480
  • gtin
    05909991482497

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Bismuthi subgallas in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All bismuthi subgallas products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/df9b0f03-0ca6-47c6-bbd1-7bbbbf631d94
GET /v1/drugs/df9b0f03-0ca6-47c6-bbd1-7bbbbf631d94?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Puder leczniczy",
  "source": "urpl",
  "strength": "100 g/100 g",
  "packaging": "05909991482480 ¦ OTC ¦ 143269\n1 sasz. 5 g\n05909991482497 ¦ OTC ¦ 143270\n1 sasz. 2 g",
  "substance": "Bismuthi subgallas 100 g/100 g",
  "common_name": "Bismuthi subgallas",
  "pl_product_id": "100434801",
  "pozwolenie_nr": "27059",
  "auth_procedure": "NAR",
  "authorisation_validity": "2027-05-09"
}

See everything about bismuthi subgallas.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.